Tentarix Biotherapeutics
Latest round
- Series B
Last raised
- Aug 2023
Total raised
- $85M
Investors
- 4
About Tentarix Biotherapeutics
Tentarix Biotherapeutics, Inc.Founded in 2020, Tentarix Biotherapeutics, Inc. operates from San Diego, US, focusing on the development of biologic candidates for cancer and immune-related diseases. The company was established by founders Margaret Karow, Michael Gallo, and Paul K. Donald Santel and Paul Grayson currently serve as CEO.Tentarix Biotherapeutics specializes in developing multifunctional biologics, particularly conditionally-active, multi-specific biologics for oncology and immunology applications. Their flagship product line, "Tentacles," focuses on analyzing cell surface proteomes for precise targeting, enhancing treatment efficacy while minimizing side effects.Tentarix Biotherapeutics generates revenue through partnerships with established pharmaceutical companies, such as AbbVie, focusing on B2B transactions that involve the co-development and distribution of proprietary biologic candidates. Revenue streams include milestone payments and royalties linked to successful development phases, along with potential sales of Tentacles products in clinical and commercial contexts. The company aims to enhance its product offerings in oncology and immunology while targeting new geographic regions for expansion. Specific markets in North America, Europe, and parts of Asia are prioritized for growth as Tentarix continues to innovate and address significant unmet therapeutic needs.
Who invested in Tentarix Biotherapeutics
4 investors across 2 rounds
See all investors in Tentarix Biotherapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Tentarix Biotherapeutics
Who invested in Tentarix Biotherapeutics?
Tentarix Biotherapeutics has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tentarix Biotherapeutics raised?
Tentarix Biotherapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Tentarix Biotherapeutics last raise money?
Tentarix Biotherapeutics's most recent round on record is a Series B, in Aug 2023.
What does Tentarix Biotherapeutics do?
Tentarix Biotherapeutics is a biotechnology company.
Where is Tentarix Biotherapeutics headquartered?
Tentarix Biotherapeutics is headquartered in San Diego, US.
Which VCs invest in companies like Tentarix Biotherapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Tentarix Biotherapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Tentarix Biotherapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.